A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
|Articles|December 28, 2022
- December 2022
- Volume 88
- Issue 12
Pharmacist Pet Peeves: December
Can you relate?
Advertisement
Gone Fishing
When a customer pulls up to the drive-through, a pharmacy employee gives them the total, and they are fishing around for exact change when they pull up.
Missed Your Shot
When a patient makes an appointment for a vaccine at the wrong store, then yells at a pharmacy employee about it.
No Need
Recommending COVID-19 boosters to patients who do not have them and they say, “Oh, no, I don’t need those. I’m fully vaccinated!”
Articles in this issue
over 3 years ago
Immunizing Older Individuals Requires Flexibility, Nuanceover 3 years ago
OTC Case Studies: Heart Healthalmost 4 years ago
Voquezna Dual Pak and Triple Pak From Phathom Pharmaceuticals, Incalmost 4 years ago
Know the Ins and Outs of Medical Marijuana in the Workplacealmost 4 years ago
December Rx Product Newsalmost 4 years ago
December OTC Product Newsalmost 4 years ago
December Interactive Case Studiesalmost 4 years ago
Set Medication Therapy Management Goals for 2023almost 4 years ago
Transparency Makes Cost-Plus Drug Pharmacies a Unique Business Modelalmost 4 years ago
Innovator Liability Theory Applies to PharmaceuticalsAdvertisement
Related to this article
A Novo Nordisk-funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, though the findings cannot show causation.
Invasive pneumococcal disease may be the first sign of undiagnosed blood cancers and antibody deficiencies in adults, a new study finds.
A new analysis finds a significant weight loss edge for tirzepatide under one estimand but not another; no head-to-head trial exists at these doses.
In SCOUT-HCM, mavacamten reduced the Valsalva LVOT gradient by 48 mm Hg versus placebo in adolescents. REMS, echo monitoring, and CYP interactions still apply in the new population.
Indirect comparison links orforglipron 17.2 mg to 1.5% more weight loss and 0.3% more A1C lowering than oral semaglutide 25 mg in adults with type 2 diabetes.
Pharmacists can help overcome influenza vaccine hesitancy by correcting common misconceptions, routinely asking every patient about vaccination, and leveraging their standing as trusted health care professionals.
Phase 3 TRIUMPH-2 data presented at EASD show HbA1C reductions up to 1.6%, with GI effects, hypotension, and dysesthesia as key counseling points.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Tirzepatide Linked to More Weight Loss Than Semaglutide 7.2 mg
2
Pharmacist, Advocate, Ally: Delivering Comprehensive Gender-Affirming Care
3
Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says
4
HIV Treatment Basics: Mechanisms, 2026 Guideline Updates, and Rapid ART Start
5